857230P

C18:1 LPA

1-(9Z-octadecenyl)-2-hydroxy-sn-glycero-3-phosphate (ammonium salt), powder

• Sinónimos: 1-O-9-(Z)-octadecenyl-sn-glycero-3-phosphate (ammonium salt); PA(18:1(9Z)e/0:0)
• Fórmula empírica (notación de Hill): C₂₁H₄₆NO₆P
• Número de CAS: 799279-68-8
• Peso molecular: 439.57
• UNSPSC Code: 51191904
• NACRES: NA.25

Propiedades

• assay: >99% (LPA; may contain up to 10% of the 2-LPA isomer, TLC)
• form: powder
• packaging: pkg of 1 × 1 mg (857230P-1mg)
• manufacturer/tradename: Avanti Research^™ - A Croda Brand 857230P
• lipid type: cardiolipins; phospholipids
• shipped in: dry ice
• storage temp.: −20°C
• SMILES string: O[C@](COP([O-])(O)=O)([H])COCCCCCCCC/C=C\CCCCCCCC.[NH4+]

Descripción

General description

C18:1 LPA is a bioactive lipid. This lysophosphatidic acid (LPA), soluble lipid is obtained from membrane phospholipid. It is present in blood plasma.

Application

C18:1 LPA is suitable to stimulate human embryonic kidney 293 cells (HEK 293) cells in luciferase assay. It is also suitable to use as an additive in Dulbecco′s modified eagle medium (DMEM) for transwell migration assay, wound‐healing assay and cell proliferation assay.

Biochem/physiol Actions

Lysophosphatidic acid (LPA) signaling participates in various cellular processes. It is also associated with neurological disorders, inflammation and cancer.

Packaging

5 mL Clear Glass Sealed Ampule (857230P-1mg)

Legal Information

Avanti Research is a trademark of Avanti Polar Lipids, LLC

Información de seguridad

• Storage Class: 11 - Combustible Solids
• wgk_germany: WGK 3
• flash_point_f: No data available
• flash_point_c: No data available